Cargando…

Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) induced by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in China and spread to cover the entire world with an ongoing pandemic. The magnitude of the situation and the fast spread of the n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sherif, Yousery E., Gabr, Sami A., Hosny, Nasser M., Alghadir, Ahmad H., Alansari, Rayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937479/
https://www.ncbi.nlm.nih.gov/pubmed/33727943
http://dx.doi.org/10.1155/2021/8814890
_version_ 1783661399140990976
author Sherif, Yousery E.
Gabr, Sami A.
Hosny, Nasser M.
Alghadir, Ahmad H.
Alansari, Rayan
author_facet Sherif, Yousery E.
Gabr, Sami A.
Hosny, Nasser M.
Alghadir, Ahmad H.
Alansari, Rayan
author_sort Sherif, Yousery E.
collection PubMed
description BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) induced by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in China and spread to cover the entire world with an ongoing pandemic. The magnitude of the situation and the fast spread of the new and deadly virus, as well as the lack of specific treatment, led to a focus on research to discover new therapeutic agents. AIM: In this study, we explore the potential inhibitory effects of some active polyphenolic constituents of Rhus spp. (sumac) against the SARS-CoV-2 main protease enzyme (M(pro); 6LU7). METHODS: 26 active polyphenolic compounds of Rhus spp. were studied for their antiviral activity by molecular docking, drug likeness, and synthetic accessibility score (SAS) as inhibitors against the SARS-CoV-2 M(pro). RESULTS: The results show that all tested compounds of sumac provided good interaction with the main active site of SARS-CoV-2 M(pro), with better, lower molecular docking energy (kcal/mol) compared to the well-known drugs chloroquine and favipiravir (Avigan). Only six active polyphenolic compounds of Rhus spp. (sumac), methyl 3,4,5-trihydroxybenzoate, (Z)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-hydroxyprop-2-en-1-one, (Z)-2-(3,4-dihydroxybenzylidene)-6-hydroxybenzofuran-3(2H)-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chroman-4-one, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4H-chroman-4-one, and 3,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, were proposed by drug likeness, solubility in water, and SAS analysis as potential inhibitors of M(pro) that may be used for the treatment of COVID-19. CONCLUSION: Six phenolic compounds of Rhus spp. are proposed for synthesis as potential inhibitors against M(pro) and have potential for the treatment of COVID-19. These results encourage further in vitro and in vivo investigations of the proposed ligands and research on the preventive use of Rhus spp. against SARS-CoV-2.
format Online
Article
Text
id pubmed-7937479
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-79374792021-03-15 Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study Sherif, Yousery E. Gabr, Sami A. Hosny, Nasser M. Alghadir, Ahmad H. Alansari, Rayan Evid Based Complement Alternat Med Research Article BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) induced by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in China and spread to cover the entire world with an ongoing pandemic. The magnitude of the situation and the fast spread of the new and deadly virus, as well as the lack of specific treatment, led to a focus on research to discover new therapeutic agents. AIM: In this study, we explore the potential inhibitory effects of some active polyphenolic constituents of Rhus spp. (sumac) against the SARS-CoV-2 main protease enzyme (M(pro); 6LU7). METHODS: 26 active polyphenolic compounds of Rhus spp. were studied for their antiviral activity by molecular docking, drug likeness, and synthetic accessibility score (SAS) as inhibitors against the SARS-CoV-2 M(pro). RESULTS: The results show that all tested compounds of sumac provided good interaction with the main active site of SARS-CoV-2 M(pro), with better, lower molecular docking energy (kcal/mol) compared to the well-known drugs chloroquine and favipiravir (Avigan). Only six active polyphenolic compounds of Rhus spp. (sumac), methyl 3,4,5-trihydroxybenzoate, (Z)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)-2-hydroxyprop-2-en-1-one, (Z)-2-(3,4-dihydroxybenzylidene)-6-hydroxybenzofuran-3(2H)-one, 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chroman-4-one, 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxy-4H-chroman-4-one, and 3,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one, were proposed by drug likeness, solubility in water, and SAS analysis as potential inhibitors of M(pro) that may be used for the treatment of COVID-19. CONCLUSION: Six phenolic compounds of Rhus spp. are proposed for synthesis as potential inhibitors against M(pro) and have potential for the treatment of COVID-19. These results encourage further in vitro and in vivo investigations of the proposed ligands and research on the preventive use of Rhus spp. against SARS-CoV-2. Hindawi 2021-02-27 /pmc/articles/PMC7937479/ /pubmed/33727943 http://dx.doi.org/10.1155/2021/8814890 Text en Copyright © 2021 Yousery E. Sherif et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sherif, Yousery E.
Gabr, Sami A.
Hosny, Nasser M.
Alghadir, Ahmad H.
Alansari, Rayan
Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
title Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
title_full Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
title_fullStr Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
title_full_unstemmed Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
title_short Phytochemicals of Rhus spp. as Potential Inhibitors of the SARS-CoV-2 Main Protease: Molecular Docking and Drug-Likeness Study
title_sort phytochemicals of rhus spp. as potential inhibitors of the sars-cov-2 main protease: molecular docking and drug-likeness study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937479/
https://www.ncbi.nlm.nih.gov/pubmed/33727943
http://dx.doi.org/10.1155/2021/8814890
work_keys_str_mv AT sherifyouserye phytochemicalsofrhussppaspotentialinhibitorsofthesarscov2mainproteasemoleculardockinganddruglikenessstudy
AT gabrsamia phytochemicalsofrhussppaspotentialinhibitorsofthesarscov2mainproteasemoleculardockinganddruglikenessstudy
AT hosnynasserm phytochemicalsofrhussppaspotentialinhibitorsofthesarscov2mainproteasemoleculardockinganddruglikenessstudy
AT alghadirahmadh phytochemicalsofrhussppaspotentialinhibitorsofthesarscov2mainproteasemoleculardockinganddruglikenessstudy
AT alansarirayan phytochemicalsofrhussppaspotentialinhibitorsofthesarscov2mainproteasemoleculardockinganddruglikenessstudy